Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jincao Tablet phase II trial for chronic pelvic pain after pelvic inflammatory disease
ChiCTR2100048057Phase 2Recruiting
- Sponsor
- Beijing Hospital of Traditional Chinese Medicine
- Start
- Aug 2020
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Jincao in Pelviabdominal infection and chronic prostatitis (CP) (3 arms), sponsored by Beijing Hospital of Traditional Chinese Medicine. Primary endpoints: Routine blood test, Urinalysis and 4 more. Started Aug 2020; status: recruiting.
02
Drugs
Jincao
03
Conditions
Pelviabdominal infectionchronic prostatitis (CP)
Beyond the preview
Go deeper on ChiCTR2100048057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100048057.